about
CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouseTreatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis.APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Anomalies in T Cell Function Are Associated With Individuals at Risk of Mycobacterium abscessus Complex Infection.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokine therapy of tuberculosis at the crossroads.
@en
Cytokine therapy of tuberculosis at the crossroads.
@nl
type
label
Cytokine therapy of tuberculosis at the crossroads.
@en
Cytokine therapy of tuberculosis at the crossroads.
@nl
prefLabel
Cytokine therapy of tuberculosis at the crossroads.
@en
Cytokine therapy of tuberculosis at the crossroads.
@nl
P2093
P2860
P356
P1476
Cytokine therapy of tuberculosis at the crossroads.
@en
P2093
Matthew J Paul
Mauricio A Arias
Rajko Reljic
P2860
P356
10.1586/17476348.3.1.53
P577
2009-02-01T00:00:00Z